Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD?

被引：2

作者：

Bafadhel, Mona ^{[1
]}

Barnes, Neil ^{[2
,3
]}

Bourke, Stephen ^{[4
,5
]}

Compton, Chris ^{[2
]}

Criner, Gerard ^{[6
]}

Dransfield, Mark ^{[7
]}

Halpin, David ^{[8
]}

Han, Meilan ^{[9
]}

Hartley, Benjamin ^{[10
]}

Jones, C. Elaine ^{[11
]}

Lange, Peter ^{[12
,13
]}

Lettis, Sally ^{[14
]}

Lipson, David ^{[15
,16
]}

Lomas, David ^{[17
]}

Martin, Neil ^{[2
,18
]}

Martinez, Fernando ^{[19
]}

Van der Valk, Ralf ^{[2
]}

Wise, Robert ^{[20
]}

Singh, David ^{[21
]}

机构：

[1] Univ Oxford, Nuffield Dept Med, Oxford, England

[2] GlaxoSmithKline, Brentford, England

[3] Barts & London Queen Marys Sch Med & Dent, London, England

[4] North Tyneside Gen Hosp, North Shields, England

[5] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England

[6] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA

[7] Univ Alabama Birmingham, Lung Hlth Ctr, Div Pulm Allergy & Crit Care Med, Birmingham, AL USA

[8] Royal Devon & Exeter Hosp, Dept Resp Med, Exeter, Devon, England

[9] Univ Michigan, Pulm & Crit Care, Ann Arbor, MI 48109 USA

[10] Veramed Ltd, Twickenham, England

[11] GlaxoSmithKline, Res Triangle Pk, NC USA

[12] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark

[13] Herlev & Gentofte Hosp, Dept Med, Herlev, Denmark

[14] GlaxoSmithKline, Uxbridge, Middx, England

[15] GlaxoSmithKline, Collegeville, PA USA

[16] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA

[17] UCL, UCL Resp, London, England

[18] Univ Leicester, Leicester, Leics, England

[19] New York Presbyterian Weill Cornell Med Ctr, New York, NY USA

[20] Johns Hopkins Med, Div Pulm & Crit Care Med, Baltimore, MD USA

[21] Univ Manchester, Manchester, Lancs, England

来源：

EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷

关键词：

D O I：

10.1183/13993003.congress-2019.OA260

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

OA260

引用

页数：3

共 47 条

[21] Late Breaking Abstract - Blood eosinophil count and exacerbation history in COPD: pooled analysis of 24,103 patients
Wedzicha, Jadwiga
Siddiqui, Salman
Calverley, Peter
De la Hoz, Alberto
Voss, Florian
Magnussen, Helgo
Rabe, Klaus F.
Singh, Dave
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[22] Blood immunoglobulin E and eosinophil levels predict treatment response to omalizumab in refractory chronic urticaria
Shin, B.
Kwon, H-S
Park, S. Y.
Yoon, S-Y
Kim, T-B
Cho, Y. S.
Moon, H-B
ALLERGY, 2013, 68 : 36 - 36
[23] Response to omalizumab treatment according to blood eosinophil count: Results of a French real-world study (STELLAIR)
Humbert, Marc
Mala, Laurence
Molimard, Mathieu
EUROPEAN RESPIRATORY JOURNAL, 2017, 50
[24] Comparison of the peripheral blood eosinophil count using near-patient testing and standard automated laboratory measurement in healthy, asthmatic and COPD subjects
Hambleton, Kirsty
Connolly, Clare M.
Borg, Catherine
Davies, Joanne H.
Jeffers, Helen P.
Russell, Richard E. K.
Bafadhel, Mona
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 2771 - 2775
[25] Economic benefit of fluticasone furoate (FF)/umeclidinium (UMEC)/vilanterol (VI) by baseline blood eosinophil (EOS) count in COPD in the UK - The IMPACT trial
Ismaila, Afisi S.
Shah, Dhvani
Martin, Alan
Kendall, Robyn
Noorduyn, Stephen G.
Dasari, Priyadarsini
Risebrough, Nancy A.
Compton, Chris
Noorduyn, Stephen G.
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[26] Parasite-specific IgG response and peripheral blood eosinophil count following albendazole treatment for presumed chronic strongyloidiasis
Karunajeewa, H
Kelly, H
Leslie, D
Leydon, J
Saykao, P
Biggs, BA
JOURNAL OF TRAVEL MEDICINE, 2006, 13 (02) : 84 - 91
[27] RESPONSE TO OMALIZUMAB TREATMENT ACCORDING TO PRE-TREATMENT BLOOD EOSINOPHIL COUNT: RESULTS OF A FRENCH REAL-WORLD STUDY (STELLAIR)
Humbert, Marc
Molimard, Mathieu
Mala, Laurence
Gavornikova, Marcela
RESPIROLOGY, 2017, 22 : 169 - 169
[28] Association between ICS treatment and blood eosinophil level with interval between severe exacerbation events among COPD patients in Malaysia: EXACOS-MY study
Musa, Aisya Natasya
Ismail, Ahmad Izuanuddin
Aflah, Syazatul Syakirin Sirol
Wong, Chee Kuan
RESPIROLOGY, 2024, 29 : 157 - 157
[29] Blood Eosinophil Count and Fractional Exhaled Nitric Oxide as a Combined Predictor of Treatment Response to Benralizumab for Patients with Severe, Eosinophilic Asthma
Katial, R.
Kreindler, J.
Hirsch, I
Newbold, P.
Gil, Garcia E. G.
PNEUMOLOGIE, 2021, 75 : S34 - S34
[30] Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD
Mathioudakis, Alexander G.
Bikov, Andras
Foden, Philip
Lahousse, Lies
Brusselle, Guy
Singh, Dave
Vestbo, Jorgen
EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (05)

← 1 2 3 4 5 →